News

2025 UK One Day meeting - 6 March - Early bird fee ends 20 February!
"Telling better stories to make an impact"
Here's a look at the speakers so far:

Gethin Nadin will be our penultimate invited speaker at the 2023 EPHMRA conference.
Paper Title - ‘The employee is now your most influential stakeholder’
Gethin will be speaking on ‘The employee is now your most influential stakeholder’ – on the final day of the 2023 EPHMRA Conference.

Gethin Nadin will be our penultimate invited speaker at the 2023 EPHMRA conference.
Paper Title - ‘The employee is now your most influential stakeholder’
Gethin will be speaking on ‘The employee is now your most influential stakeholder’ – on the final day of the 2023 EPHMRA Conference.

At the 2023 EPHMRA Conference…
Marina Panizza, General Manager, Stethos - will be presenting her paper -
Shedding light on the subconscious component of thinking with Neuromarketing to support market research in the pharma world.

Kicking off day 3 of the 2023 EPHMRA conference is the paper…

Future Leaders – Case Study Award (sponsored by Blueprint Partnership)
15 June 3-3:30 UK time
Abigail Graham, Senior Research Manager, HRW will be presenting her paper: Hearing the Unheard Patient Voice in Digital Therapeutics
Convenor: Mike Pepp, Blueprint Partnership

Join us at the 2023 EPHMRA Conference and hear about the paper...
‘More than “just” an insight: how a fully integrated client + research + consultancy team went beyond the brief and into action’

Join us to hear the paper from...
Lauren Halliwell, EU Neurology Market Insight Manager, UCB and Victoria Weaver, Director, Basis Research and their paper – ‘Dynamics and disconnects - A fly on the wall in patient consultations’

Take a look at this paper 👀
‘Oncologists: Uncovering their deepest desires’ – presented by speakers...
Abigail Stuart, Founding Partner, Day One Strategy and Julie Jenson, The Hidden Depth

At the 2023 EPHMRA Conference…
Tracy Machado, Senior Research Director, Elma Research and Alberto Giovanni Leone, IRCCS Istituto Nazionale dei Tumori di Milano present the paper – ‘Gender identity perspective - deep dive into oncology screening’.